Proportion of adult patients with a new CIED with an in-person evaluation within 2 to 12 weeks following implantation.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
This measures assess the number of patients from the denominator with an in-person evaluation within 2-12 weeks following implantation. For the purposes of this measure, an “in-person evaluation” is defined as an in-person interrogation device evaluation either with or without iterative adjustment, as clinically indicated. The in-person evaluation can be provided by any trained physician or Clinically Employed Allied Professional (CEAP) in a designated CIED follow-up clinic, medical institution, or physician office.
-
1.15 Denominator
All Medicare FFS patients with implantation of a new CIED during the reporting period. CIEDs encompassed for this measure are the following devices:
• Pacemakers (PMs)
• Implantable cardioverter-defibrillators (ICDs)
• Cardiac resynchronization devices (CRTs)
-
Exclusions
Exclude patients with any of the following diagnoses/conditions:
1. Patients with Implantable Loop Recorders or Implantable Cardiovascular Monitors.
2. Patients with pulse generator exchange only.
3. Patients with prior CIED implantation.
4. Patient preference for other or no treatment.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityEndorsed Cardiovascular Project 2014-2015Initial EndorsementLast Updated
-
StewardSteward Organization EmailSteward Organization Copyright
© 2014 Heart Rhythm Society. All Rights Reserved.
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)
-